Viking Therapeutics, Inc. - Common Stock (NQ:VKTX)
29.20
-1.07
(-3.53%)
Streaming Delayed Price
Updated: 11:35 AM EDT, May 18, 2026
Add to My Watchlist
Price and Volume
Detailed Quote| Volume | 809,134 |
| Open | 30.28 |
| Bid (Size) | 29.18 (100) |
| Ask (Size) | 29.25 (100) |
| Prev. Close | 30.27 |
| Today's Range | 29.18 - 30.43 |
| 52wk Range | 22.96 - 43.15 |
| Shares Outstanding | 99,581,693 |
| Dividend Yield | N/A |
Top News
More News
Performance
More News
Read More
Better Long-Term Buy: Eli Lilly or Viking Therapeutics? ↗
April 17, 2026
Where Will Viking Therapeutics Stock Be in 10 Years? ↗
April 03, 2026
1 Reason This Biotech Stock Could Triple Before Year-End ↗
March 29, 2026
Frequently Asked Questions
Is Viking Therapeutics, Inc. - Common Stock publicly traded?
Yes, Viking Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Viking Therapeutics, Inc. - Common Stock trade on?
Viking Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Viking Therapeutics, Inc. - Common Stock?
The ticker symbol for Viking Therapeutics, Inc. - Common Stock is VKTX on the Nasdaq Stock Market
What is the current price of Viking Therapeutics, Inc. - Common Stock?
The current price of Viking Therapeutics, Inc. - Common Stock is 29.20
When was Viking Therapeutics, Inc. - Common Stock last traded?
The last trade of Viking Therapeutics, Inc. - Common Stock was at 05/18/26 11:35 AM ET
What is the market capitalization of Viking Therapeutics, Inc. - Common Stock?
The market capitalization of Viking Therapeutics, Inc. - Common Stock is 2.91B
How many shares of Viking Therapeutics, Inc. - Common Stock are outstanding?
Viking Therapeutics, Inc. - Common Stock has 3B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.